Studies have shown that cyclooxygenase-2 (COX-2) plays a role in the occurrence and development of hepatocellular carcinoma, and selective COX-2 inhibitors (COX-2 inhibitors) have obvious anti proliferative and pro apoptotic effects in human HCC cell lines [11–13]. This evidence concerns the gene PTGS2 and hepatocellular carcinoma.